Ofloxacine Biogaran

Ofloxacin, the active ingredient in Ofloxacine Biogaren, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxacine Biogaren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacine Biogaren is a broad‑spectrum antibacterial agent that acts on Gram‑negative and Gram‑positive pathogens in several organ systems. - Urinary tract infection: helps reduce bacterial load and resolves infection symptoms. - Respiratory tract infection: aids in clearing the causative bacteria and improves breathing comfort. - Skin and soft‑tissue infection: assists in eradic the infecting organisms and promotes lesion healing.

Ofloxacine Biogaren may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset often reported. - Diarrhea: loose stools occurring during treatment. - Headache: transient head pain without neurological signs. - Dizziness: brief episodes of light‑headedness. - Rash: skin redness or mild itching. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT prolongation: abnormal heart rhythm detectable on ECG. - Severe allergic reaction: swelling, hives, or breathing difficulty. - Peripheral neuropathy: tingling or numbness in extremities. - Hepatotoxicity: elevated liver enzymes or jaundice. - Clostridioides difficile infection: severe diarrhea after antibiotic use.

Before prescribing Ofloxacine Biogaren, clinicians should evaluate patient history and potential risk factors. - Renal impairment: adjust dose or monitor renal function. - Hepatic dysfunction: use with caution in liver disease. - Pregnancy: avoid unless clearly needed, discuss risks. - Elderly patients: monitor for tendon injury and CNS effects. - Concomitant QT‑prolonging drugs: assess cardiac risk. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Ofloxacine Biogaren can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce absorption of ofloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of CNS stimulation.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased chance of tendon rupture. - Diabetic agents: possible alteration of blood glucose control. - Theophylline: may raise plasma levels and cause toxicity.